Search results
Profound Medical Announces First Quarter 2024 Financial Results and Issues Full-Year 2024 Revenue...
Digital Journal· 4 days agoTORONTO, May 09, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable ...
New Day Aims to Enter CRC Screening Market With Combined PCR, Immunoassay Test
GenomeWeb News· 1 week agoWith technologies brought under one roof through a pair of deals last summer, New Day Diagnostics aims to complete within the next two years the development of a blood-based screening test utilizing ...